节点文献

商陆抗病毒蛋白对感染细胞模型中HCV复制的影响

Influence of Pokeweed antiviral protein on hepatitis C virus replication in an infection cell model

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 陈瑞烈林少锐李忆璇郑晓丹贺永文高勇杨小铭罗端德

【Author】 CHEN Rui-lie, LIN Shao-rui, LI Yi-xuan, et al. Department of Infectious Disease,Shantou Central Hospital.(Shantou Guangdong , 515031)China

【机构】 汕头市中心医院感染科华中科技大学同济医学院附属协和医院传染病教研室华中科技大学同济医学院附属协和医院传染病教研室 广东汕头515031广东汕头

【摘要】 目的:探讨商陆抗病毒蛋白(PAP)对丙型肝炎病毒(HCV)感染细胞模型中HCV复制的影响。方法:用不同浓度PAP处理HCV感染细胞模型(HCV-HepG2),以荧光定量PCR法检测培养上清液中及细胞内HCV RNA,以不同浓度的α-2b干扰素(IFNα-2b)处理同样的细胞模型作为对照。结果:经PAP处理后各模型组细胞内HCVRNA含量于48小时、96小时和144小时进行比较,差异有非常显著性意义(P<0·01);培养上清液中HCV RNA含量在48小时时,各组间比较,差异无显著性意义(P>0·05),但在96小时和144小时时,各组间比较差异有非常显著性意义(P<0·01)。PAP对HCV的抑制作用随PAP浓度的增加而增强,以100μg/ml浓度的抑制作用最强。用IFN-α2b处理HCV-HepG2模型亦得出类似的结果。两者均以第48小时的抑制率最高。但在96小时、144小时时PAP对细胞内HCV的抑制作用明显强于IFN(P<0·05,P<0·01)。结论:PAP对HCV感染细胞模型中的HCV复制有明显地抑制作用,且作用强于IFN-α2b。PAP对细胞无明显毒性。

【Abstract】 Objective:To investigate the influence of Pokeweed antiviral protein (PAP) on hepatitis C virus (HCV) replication in an infection cell model(HepG2).Methods:Using fluorescent quantitative PCR to test the copies of HCV RNA in the infected cells treated with different concentration of PAP, as well as the supernatant. Interferon α-2b (IFNα-2b) treatment was used as a control.Results: HCV RNA copies in the infected cells were significantly different among different groups at 48, 96,144 hours post PAP treatment(P<0.01).HCV RNA copies in the supernatant were also significantly different at 96, 144 hours post PAP treatment (P<0.01),but not at 48 hours(P>0.05). The inhibition efficiency of APA on HCV replication increased when using higher concentration, and reached up to the peak at 100μg/ml. Similar results were obtaind from the IFNα-2b treated groups. The inhibition efficiency of both PAP and IFNα-2b were the highest at 48 hours post-treatment, however, PAP was more efficient than IFNα-2b at 96 hours and 144 hours post-treatment (P<0.05,P<0.01). Conclusion:PAP can efficiently inhibit HCV replication in the HepG2 cell model, and its efficiency is higher than IFNα-2b. PAP is not obviously toxic to the HepG2 cells.

【基金】 汕头市科技局科研基金资助[汕府科(2006)82号]
  • 【文献出处】 中西医结合肝病杂志 ,Chinese Journal of Integrated Traditional and Western Medicine on Liver Diseases , 编辑部邮箱 ,2006年04期
  • 【分类号】R373
  • 【被引频次】2
  • 【下载频次】115
节点文献中: 

本文链接的文献网络图示:

本文的引文网络